Health Systems Innovation Lab Collaborates to Transform Global Health

Key Points:

• The Health Systems Innovation Lab (HSIL) at Harvard T.H. Chan School of Public Health is working to create strategic public-private partnerships to tackle global health challenges.
• HSIL has formed collaborations with pharmaceutical companies Novartis and Novo Nordisk to design and measure the impact of these partnerships.
• The goal is to help countries transition to “high-value health systems” that focus on efficiency, effectiveness, equity, and responsiveness of public health and healthcare services.
• HSIL released a report outlining 10 components for measuring high-value health systems, which includes digital data systems and measuring health outcomes.
• Recent efforts by HSIL include panel discussions on data analytics for cardiovascular disease care in Brazil and scaling up cancer care in Latin America. They also host an annual hackathon to foster innovation in developing high-value health systems.
• HSIL is working on creating a database of health-related laws and policies worldwide, using machine learning to identify commonalities and help policymakers develop effective policies.

Hot Take:

The Health Systems Innovation Lab is like the superhero of the global health world, bringing together researchers, policymakers, and even pharmaceutical companies to tackle health challenges. With a focus on creating high-value health systems, they’re all about getting the most bang for your buck when it comes to public health and healthcare services. Plus, their annual hackathon sounds like a fun and innovative way to harness the power of artificial intelligence. Keep up the great work, HSIL!

Original article:https://www.hsph.harvard.edu/news/features/sparking-innovation-global-health-systems/